ATL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.671600E-01
Normal-vs-Stage2
6.744400E-01
Normal-vs-Stage3
4.481800E-01
Normal-vs-Stage4
8.544000E-01
Stage1-vs-Stage2
6.027200E-01
Stage1-vs-Stage3
3.108800E-01
Stage1-vs-Stage4
7.552600E-01
Stage2-vs-Stage3
4.843800E-01
Stage2-vs-Stage4
4.214400E-01
Stage3-vs-Stage4
2.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.894400E-01
Normal-vs-AfricanAmerican
7.297600E-01
Normal-vs-Asian
5.348200E-01
Caucasian-vs-AfricanAmerican
2.949000E-01
Caucasian-vs-Asian
4.360000E-01
AfricanAmerican-vs-Asian
1.889820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.426600E-01
Normal-vs-Female
8.845200E-01
Male-vs-Female
4.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.478600E-01
Normal-vs-Age(41-60Yrs)
7.576400E-01
Normal-vs-Age(61-80Yrs)
5.911600E-01
Normal-vs-Age(81-100Yrs)
3.181200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.961800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.989400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.621200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.743200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.402000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.018800E-01
Normal-vs-Daily Drinker
7.224000E-01
Normal-vs-Weekly Drinker
4.394600E-01
Normal-vs-Occasional Drinker
7.974800E-01
Normal-vs-Social Drinker
8.719000E-01
Non Drinker-vs-Daily Drinker
6.795400E-01
Non Drinker-vs-Weekly Drinker
9.909400E-01
Non Drinker-vs-Occasional Drinker
3.886100E-02
Non Drinker-vs-Social Drinker
7.124100E-02
Daily Drinker-vs-Weekly Drinker
7.320600E-01
Daily Drinker-vs-Occasional Drinker
2.389600E-01
Daily Drinker-vs-Social Drinker
3.379400E-01
Weekly Drinker-vs-Occasional Drinker
1.046810E-01
Weekly Drinker-vs-Social Drinker
1.465190E-01
Occasional Drinker-vs-Social Drinker
8.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.045820E-01
Normal-vs-Grade 2
9.360500E-03
Normal-vs-Grade 3
1.566440E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.921600E-01
Grade 1-vs-Grade 3
1.385190E-01
Grade 1-vs-Grade 4
1.045820E-01
Grade 2-vs-Grade 3
3.195000E-01
Grade 2-vs-Grade 4
9.360500E-03
Grade 3-vs-Grade 4
1.566440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.293600E-01
Normal-vs-NonDiabetic
7.943600E-01
Diabetic-vs-NonDiabetic
5.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.428200E-01
Normal-vs-NoPancreatitis
7.241400E-01
Pancreatitis-vs-NoPancreatitis
4.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.785000E-01
Normal-vs-N1
7.370400E-01
N0-vs-N1
6.916000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.176200E-01
Normal-vs-TP53-NonMutant
9.180600E-01
TP53-Mutant-vs-TP53-NonMutant
1.964340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
